Dow Chemical Readies for a New Era of Superweeds

We're going to get them anyway, the thinking goes, so we may as deregulate their causation now.

Jan 12, 2014 at 1:15PM

Because of the overuse of Monsanto's (NYSE:MON) Roundup weedkiller, farmers have created "superweeds" that resist the best efforts of the herbicide to eradicate them. So rather than address the problem at the source, the USDA is poised to compound it by approving new seeds that are resistant to a different weedkiller manufactured by Dow Chemical (NYSE:DOW), meaning it won't be long before we have to up the ante once more.



Dow AgroSciences makes Enlist Weed Control System, the third leading herbicide, but whose constituent component -- 2,4-D -- is perhaps also best known as one half of the deadly Vietnam War-era herbicide Agent Orange. Both Monsanto and Dow were the two primary government contractors that manufactured the deadly defoliant, though scientists think its extreme health risks were due more to the dioxin found in its other component, 2,4,5-T.

Like the Roundup Ready seeds that Monsanto genetically modified to withstand an application of its herbicide, the Agriculture Department wants to deregulate corn and soybean seeds that have been genetically modified to resist 2,4-D. Although they acknowledge it will likely lead to the creation of new superweeds down the road, their logic is that because we're overusing the herbicide as it is -- farmers who grow genetically modified crops typically use 25% more herbicide than those who grow traditional seeds -- we'll get superweeds sooner or later anyway, so there's no need to regulate the seeds anymore.

While the EPA is separately investigating 2,4-D and will soon issue its own report on its use and the seeds' deregulation, Dow AgroSciences has petitioned the USDA to deregulate one corn and two soybean seed varieties that are resistant to 2,4-D and glyphosate, the generic form of Roundup. Last year Monsanto and Dow agreed to cross-license their weed-control technology, with Monsanto using Dow's Enlist herbicide-tolerant traits in field corn while the AgroSciences division would use Monsanto's Corn Rootworm III traits, a third-generation corn rootworm technology still under development. 

Yet the insects are developing immunity to the chemicals, too, creating new superbugs!  But that's good business for the likes of Syngenta (NYSE:SYT), FMC (NYSE:FMC), and American Vanguard (NYSE:AVD), the three leading pesticide manufacturers that account for three-quarters of all such chemicals sold in the United States. Trailing revenues of the trio were up more than 13% on average over the past year and 14% over the past three years, even as GMO crops and increased pesticide use are believed to have a leading role in colony collapse disorder and the destruction of honeybee populations.

Like someone caught in a revolving door, the industrial farming complex keeps going round and round developing new chemicals to kill off the weeds and insects that grew resistant to the last batch that was applied. Monsanto and BASF are also pushing for regulatory approval of other new genetically altered seeds -- soybeans and cotton -- that resist a new dicamba-based herbicide.

And though we're promised that these genetically modified seeds able to withstand the application of powerful herbicides and insecticides but still keep growing are safe for human consumption, it hardly seems a prescription for a healthy diet, let alone a sustainable future.

Biotechnology without the scary stuff
The best way to play the biotech space is to find companies that shun the status quo and instead discover revolutionary, groundbreaking technologies. In The Motley Fool's brand-new free report "2 Game-Changing Biotechs Revolutionizing the Way We Treat Cancer," find out about a new technology that Big Pharma is endorsing through partnerships, and the two companies that are set to profit from this emerging drug class. Click here to get your copy today.

Fool contributor Rich Duprey and The Motley Fool have no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

A Financial Plan on an Index Card

Keeping it simple.

Aug 7, 2015 at 11:26AM

Two years ago, University of Chicago professor Harold Pollack wrote his entire financial plan on an index card.

It blew up. People loved the idea. Financial advice is often intentionally complicated. Obscurity lets advisors charge higher fees. But the most important parts are painfully simple. Here's how Pollack put it:

The card came out of chat I had regarding what I view as the financial industry's basic dilemma: The best investment advice fits on an index card. A commenter asked for the actual index card. Although I was originally speaking in metaphor, I grabbed a pen and one of my daughter's note cards, scribbled this out in maybe three minutes, snapped a picture with my iPhone, and the rest was history.

More advisors and investors caught onto the idea and started writing their own financial plans on a single index card.

I love the exercise, because it makes you think about what's important and forces you to be succinct.

So, here's my index-card financial plan:


Everything else is details. 

Something big just happened

I don't know about you, but I always pay attention when one of the best growth investors in the world gives me a stock tip. Motley Fool co-founder David Gardner (whose growth-stock newsletter was rated #1 in the world by The Wall Street Journal)* and his brother, Motley Fool CEO Tom Gardner, just revealed two brand new stock recommendations moments ago. Together, they've tripled the stock market's return over 12+ years. And while timing isn't everything, the history of Tom and David's stock picks shows that it pays to get in early on their ideas.

Click here to be among the first people to hear about David and Tom's newest stock recommendations.

*"Look Who's on Top Now" appeared in The Wall Street Journal which references Hulbert's rankings of the best performing stock picking newsletters over a 5-year period from 2008-2013.